Glowderma Lab Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 15-12-2024
- Paid Up Capital ₹ 2.10 Cr
as on 15-12-2024
- Company Age 21 Year, 29 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 17.42 Cr
as on 15-12-2024
- Revenue -24.14%
(FY 2023)
- Profit -165.51%
(FY 2023)
- Ebitda -110.34%
(FY 2023)
- Net Worth -11.62%
(FY 2023)
- Total Assets 0.95%
(FY 2023)
About Glowderma Lab
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.10 Cr.
The company currently has active open charges totaling ₹17.42 Cr.
Rajeshkumar Khatri, Ashaben Khatri, and Shailesh Khatri serve as directors at the Company.
- CIN/LLPIN
U24230MH2003PTC143343
- Company No.
143343
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Glowderma Lab?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeshkumar Khatri  | Director | 02-Dec-2003 | Current |
| Ashaben Khatri | Director | 02-Dec-2003 | Current |
| Shailesh Khatri | Director | 18-Jul-2005 | Current |
Financial Performance of Glowderma Lab.
Glowderma Lab Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.14% decrease. The company also saw a substantial fall in profitability, with a 165.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glowderma Lab?
In 2023, Glowderma Lab had a promoter holding of 80.86% and a public holding of 19.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vida Pret & Couture LlpActive 10 years 11 monthsRajeshkumar Khatri and Ashaben Khatri are mutual person
- Amorvin Holdings Private LimitedActive 3 years 2 months
Rajeshkumar Khatri and Ashaben Khatri are mutual person
- Orane Infotech Private LimitedActive 13 years 6 months
Rajeshkumar Khatri and Shailesh Khatri are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Mar 2022 | ₹3.89 Cr | Open |
Others Creation Date: 29 Mar 2022 | ₹2.53 M | Open |
Axis Bank Limited Creation Date: 15 Dec 2021 | ₹3.63 M | Open |
How Many Employees Work at Glowderma Lab?
Glowderma Lab has a workforce of 327 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glowderma Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glowderma Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
